Patents and Fundraising: What Investors Actually Ask

Investors rarely expect an early-stage startup to have issued patents. What they want to know is whether the company owns its core technology, whether that technology is protected or protectable, whether anyone else’s rights could block the product, and whether the founders have a sensible plan for intellectual property as the company grows. Being ready with clear answers often matters more than the number of filings.

This guide covers the questions that come up and how to prepare for them at each stage.

The first question: does the company own its technology?

Before investors care about patents, they care about ownership. Diligence usually checks:

• Invention assignment agreements. Has every founder, employee, and contractor who worked on the technology signed an agreement assigning inventions to the company? These are often part of a proprietary information and inventions agreement.
• Work done before incorporation. Technology developed by founders before the company existed generally needs to be assigned to it in writing.
• Former employers and universities. Did any founder develop the technology while employed elsewhere, or using a university’s resources? Employment agreements and university policies can create competing claims.
• Contractors and development firms. Outside developers may own what they create unless their contracts say otherwise.
• Open-source components. Which licenses apply to code in the product, and do any of them impose obligations that could affect the business?

For any patent applications already filed, investors may check that assignments to the company were signed and recorded at the USPTO. Recording an assignment within three months of its execution, or before a later purchase or mortgage, protects against subsequent purchasers who lack notice (35 U.S.C. 261).

Gaps here are common diligence findings, and they are generally much easier to fix before a financing than during one.

What investors often look for at each stage

Expectations vary by investor, sector, and deal, so treat the following as common patterns rather than rules.

Pre-seed and seed. A provisional or non-provisional application on the core technology, clean ownership documents, and an understanding of the key competitors’ patents is usually enough. Investors mostly want to see that IP has been considered, not that a portfolio exists.

Seed to Series A. Decisions that fall due about 12 months after the first filing, such as whether to convert a provisional to a non-provisional application and whether to file internationally, often coincide with this stage. Investors may ask about the claims being pursued and how they relate to the product.

Series A and later. Expect questions about a portfolio plan: which products and technical areas are covered, what is pending, what is planned, and how filings track the roadmap. Freedom to operate concerns, any demand letters received, and competitors’ patent activity get more attention.

“Patent pending” in a pitch deck

“Patent pending” is accurate once an application has been filed and is still pending, including a provisional application. It does not mean a patent will issue or what its claims will cover, and experienced investors understand that.

Two cautions apply. Be precise: describing a pending application as a patent, or overstating what it covers, can damage credibility in diligence and raise legal issues. And be careful about technical detail in decks, because many investors will not sign nondisclosure agreements. Describe what the technology achieves and why it is hard to replicate, and keep implementation details for after a filing is in place.

Questions to be ready for

A short preparation list covers most investor IP questions:

1. What patent applications have been filed, when, and in which countries?
2. What do the claims aim to cover, in plain language?
3. Does the company own everything it needs, with signed assignments from every contributor?
4. Has anyone asserted patents against the company or its products?
5. Are there competitors’ patents that could affect the product, and has anyone looked?
6. What is the plan for the next 12 to 24 months, and what will it cost?
7. Are there any licenses in or out, including university licenses?

Having a one-page summary that answers these questions, along with copies of filings and assignments in the data room, shortens diligence and signals that the company is well run.

Representations in the financing documents

Financing documents commonly include representations by the company about its intellectual property, such as ownership of its technology and the absence of known infringement claims. Founders should understand what they are representing and disclose exceptions accurately. Your corporate counsel handles these documents, and it helps to coordinate them with whoever manages your patents.

Spending wisely before and after a round

Patent spending competes with runway. A common approach is to file a thorough first application on the core technology before fundraising conversations become public, keep ownership documents clean from day one, and expand the portfolio once the round closes and the product direction is clearer. Timing the 12-month decisions after the first filing to fit the fundraising calendar is often possible with some planning.

A practical takeaway

Before a round, it helps to confirm that every contributor has assigned their inventions to the company, gather filings and assignments in one place, and prepare a one-page summary of what is filed, what it covers, and what is planned. Reviewing that summary with your patent attorney or agent, and with corporate counsel, helps keep the answers accurate and consistent when investors ask.